Risk of pre-eclampsia in patients with a maternal genetic predisposition to common medical conditions: a case-control study.

Abstract

To assess whether women with a genetic predisposition to medical conditions known to increase pre-eclampsia risk have an increased risk of pre-eclampsia in pregnancy. Case-control study. Pre-eclampsia cases (n=498) and controls (n=1864) in women of European ancestry from five US sites genotyped on a cardiovascular gene-centric array. Significant single-nucleotide polymorphisms (SNPs) from 21 traits in seven disease categories (cardiovascular, inflammatory/autoimmune, insulin resistance, liver, obesity, renal and thrombophilia) with published genome-wide association studies (GWAS) were used to create a genetic instrument for each trait. Multivariable logistic regression was used to test the association of each continuous scaled genetic instrument with pre-eclampsia. Odds of pre-eclampsia were compared across quartiles of the genetic instrument and evaluated for significance. Genetic predisposition to medical conditions and relationship with pre-eclampsia. An increasing burden of risk alleles for elevated diastolic blood pressure (DBP) and increased body mass index (BMI) were associated with an increased risk of pre-eclampsia (DBP, overall OR 1.11, 95%CI 1.01-1.21, P=0.025; BMI, OR 1.10, 95%CI 1.00-1.20, P=0.042), whereas alleles associated with elevated alkaline phosphatase (ALP) were protective (OR 0.89, 95%CI 0.82-0.97, P=0.008), driven primarily by pleiotropic effects of variants in the FADS gene region. The effect of DBP genetic loci was even greater in early-onset pre-eclampsia cases (at <34weeks of gestation, OR 1.30, 95%CI 1.08-1.56, P=0.005). For other traits, there was no evidence of an association. These results suggest that the underlying genetic architecture of pre-eclampsia may be shared with other disorders, specifically hypertension and obesity. A genetic predisposition to increased diastolic blood pressure and obesity increases the risk of pre-eclampsia.